BackZivo Bioscience- Warrants (29/04/2026) Overview
Zivo Bioscience Inc - Warrants (29/04/2026)

Zivo Bioscience- Warrants (29/04/2026) Return on Equity

Zivo Bioscience- Warrants (29/04/2026) (ZIVOW) has a ROE of 193.68%, above the Consumer Discretionary sector average of 23.6%.

Get informed when a big investor buys or sells

+ Follow

ROE

193.68%

Return on Equity

193.68%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Zivo Bioscience- Warrants (29/04/2026) (ZIVOW) FAQ

As of the most recent data, ZIVOW shows a ROE of 193.68%. That is above the Consumer Discretionary sector average of 23.6%. Scroll down for historical charts and peer comparison views.

The Consumer Discretionary sector average ROE is about 23.6%. Zivo Bioscience- Warrants (29/04/2026) is at 193.68%, which is higher that average. That is roughly 720.8% above the sector mean. Use the comparison chart on this page to see how ZIVOW stacks up against individual peers as well.

Check the historical chart to see whether ZIVOW's ROE is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Zivo Bioscience- Warrants (29/04/2026) with peers to see if the move is company-specific or sector-wide.

Besides this return on equity page, Stockcircle has Zivo Bioscience- Warrants (29/04/2026)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect ROE (currently 193.68%) with ownership activity and broader fundamentals.

The Consumer Discretionary average ROE is about 23.6%, while ZIVOW is at 193.68%. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.